• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

A Billionaire's Dividend Picks

Here's what Glen Dubin's Highbridge funds have been buying.
By MEENA KRISHNAMSETTY Aug 22, 2013 | 11:30 AM EDT
Stocks quotes in this article: ABBV, PMT, VZ, MCD, LLY

One common misconception about hedge funds' quarterly 13F filings is that because this information is old (the most recent filings disclose many long equity positions as of the end of June), it is useless for investors. Not so. Our research has shown that the most popular small-cap stocks among hedge funds earn an average excess return of 18 percentage points per year, and our own portfolio based on this strategy has outperformed the S&P 500 by 33 percentage points in the last 11 months.

We believe that using hedge funds' picks as a screen of stocks in a number of areas, including dividend stocks, and then doing further research on any interesting names, can also be useful, although it's tough to quantify any additional returns that investors might see. Read on for our quick take on the five largest positions in billionaire Glenn Dubin's Highbridge Capital Management's most recent 13F portfolio which currently pay dividend yields of 3% or higher.

Dubin and his team increased the size of their position in the pharmaceutical company Abbvie (ABBV) to a total of 1.1 million shares. Abbvie has a $68 billion market cap and trades at 13x trailing earnings, whether we compare that valuation with its trailing results or with Wall Street analysts' expectations for 2014. At quarterly dividend payments of $0.40 per share, the stock's yield is 3.7%, which is fairly high even for a large drug manufacturer. Both revenue and operating income were up slightly in the second quarter of 2013 from a year earlier, so at current prices it could be a value prospect.

Highbridge cut its stake in Pennymac Mortgage Investment Trust (PMT) but still closed June with 2.1 million shares in its portfolio. As a real estate investment trust, Pennymac receives favorable tax treatment that is conditional on distributing a large share of taxable income to shareholders. REITs therefore often pay high yields, and Pennymac's is quite high at over 10%. However, this yield reflects the risks inherent in the company's business: Pennymac invests in residential mortgage loans, and many similar companies encountered significant difficulties during the recent financial crisis and recession.

The fund was buying Verizon (VZ) last quarter, making the large telecom another of its dividend picks, given that stock's annual yield of 4.3%. Revenue grew by 4%, according to Verizon's last quarterly report, compared with the second quarter of 2012, and since margins are expanding as well, this resulted in an impressive growth rate on the bottom line. The sell side expects good results to continue next year, and in fact, Verizon looks reasonably priced at a valuation of 15x forward earnings estimates. As with many large telecoms, it is also a quite defensive stock, having a beta of 0.2.

The 13F shows that Highbridge had a little over 400,000 shares of McDonald's (MCD) in its portfolio at the beginning of July. Another classic defensive pick, this quick-service restaurant features a beta of 0.2 and a dividend yield of a little over 3%. Recent reports show only modest growth, however, and the trailing and forward P/Es are 17 and 16 respectively. While those multiples represent a discount to the stocks of many other quick-service restaurants, on an absolute basis they make McDonald's look a bit pricey to us. As a result, we would avoid it, at least for now.

Eli Lilly (LLY) rounds out our list of Dubin's favorite dividend stocks; the filing disclosed ownership of about 780,000 shares. While the pharmaceutical company's net income has been up recently, analysts believe that this is only temporary, and they are calling for earnings per share of $2.77 in 2014. This makes for a forward earnings multiple of 19, and so Eli Lilly would have to rebound from these results with moderate to high growth rates. At current prices and dividend levels, the yield is 3.7% -- the same level as that of Abbvie.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Krishnamsetty did not own shares in any of the stocks mentioned in this article.

TAGS: Investing | U.S. Equity | Healthcare | Consumer Discretionary

More from Healthcare

Nuvalent Has Begun the Bottoming Process

Bruce Kamich
Jul 1, 2022 10:52 AM EDT

Let's check the charts and indicators.

CRISPR Therapeutics Has Turned the Corner

Bruce Kamich
Jul 1, 2022 8:43 AM EDT

Here's our current price target.

Johnson & Johnson Appears to Be Running Out of Steam

Bruce Kamich
Jun 22, 2022 8:25 AM EDT

The shares of the healthcare giant have been in a long-term uptrend but could break that trend in the weeks ahead.

Anthem's Long-Term Uptrend Is Losing Its Vigor

Bruce Kamich
Jun 22, 2022 7:40 AM EDT

The technical signals of the health benefits provider are weakening.

Here Are 2 Prudent Healthcare Trades

Bret Jensen
Jun 17, 2022 11:30 AM EDT

The country might be heading into recession, but folks still need to get their medicine, good times or bad.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:49 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Stop Wishing, Hoping, and Praying and Take Control...
  • 07:59 PM EDT PAUL PRICE

    Very Good Quarterly Numbers From Bassett Furniture (BSET)

    Bassett Furniture blew right through analysts es...
  • 04:41 PM EDT PAUL PRICE

    First-Half Results - Putrid; Second Half Results - Likely to Be Much Better

    It's great that we're done with June. 2022 mark...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login